Bayer CropScience Ltd

Bayer Crop Sci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bayer CropScience Ltd

₹ 6,587 -1.59%
02 Jul 2:41 p.m.
bayer.in BSE: 506285 NSE: BAYERCROP
About

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Key Points

Business Areas

Website BSE NSE
  • Market Cap ₹ 29,604 Cr.
  • Current Price ₹ 6,587
  • High / Low ₹ 6,977 / 4,351
  • Stock P/E 40.0
  • Book Value ₹ 634
  • Dividend Yield 1.98 %
  • ROCE 33.8 %
  • ROE 26.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.4%
  • Company has been maintaining a healthy dividend payout of 88.8%

Cons

  • Stock is trading at 10.4 times its book value
  • The company has delivered a poor sales growth of 10.0% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Multinational

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
734 1,416 1,365 990 963 1,667 1,452 1,038 982 1,740 1,617 955 792
651 1,094 1,143 924 763 1,272 1,214 952 777 1,315 1,312 827 695
Operating Profit 83 322 222 66 201 395 238 85 206 425 305 128 97
OPM % 11% 23% 16% 7% 21% 24% 16% 8% 21% 24% 19% 13% 12%
22 15 14 68 16 14 14 116 24 21 16 15 30
Interest 4 2 2 3 6 4 8 3 7 8 4 3 5
Depreciation 22 15 14 14 21 23 15 14 27 31 12 15 16
Profit before tax 80 320 220 118 190 382 229 184 195 406 306 124 105
Tax % 22% 21% 30% 28% 19% 21% 29% 27% 19% 19% 27% 25% 9%
62 254 154 85 153 303 163 134 158 328 223 93 96
EPS in Rs 13.77 56.45 34.29 18.87 33.98 67.33 36.18 29.93 35.27 73.09 49.60 20.72 21.36
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2,682 3,188 3,660 2,769 2,803 2,710 3,167 3,609 4,261 4,734 5,140 5,103
2,321 2,768 3,144 2,334 2,389 2,300 2,684 2,883 3,450 3,923 4,216 4,149
Operating Profit 362 419 516 435 414 410 483 726 812 812 924 954
OPM % 13% 13% 14% 16% 15% 15% 15% 20% 19% 17% 18% 19%
1,242 91 88 82 70 39 51 -64 69 112 168 81
Interest 4 5 5 10 7 11 10 14 13 13 22 20
Depreciation 37 65 25 25 29 33 44 65 74 64 80 74
Profit before tax 1,563 441 574 482 448 404 480 583 794 847 990 941
Tax % 26% 34% 33% 35% 35% 26% 30% 19% 38% 24% 23% 21%
1,162 290 383 315 291 300 337 474 493 645 758 740
EPS in Rs 294.11 79.06 104.59 89.13 82.31 87.41 98.18 105.58 109.72 143.58 168.71 164.77
Dividend Payout % 2% 7% 20% 19% 21% 21% 18% 24% 105% 104% 77% 85%
Compounded Sales Growth
10 Years: 5%
5 Years: 10%
3 Years: 6%
TTM: -1%
Compounded Profit Growth
10 Years: 10%
5 Years: 17%
3 Years: 15%
TTM: 9%
Stock Price CAGR
10 Years: 14%
5 Years: 15%
3 Years: 6%
1 Year: 51%
Return on Equity
10 Years: 21%
5 Years: 24%
3 Years: 25%
Last Year: 27%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 40 37 37 35 35 34 34 45 45 45 45 45
Reserves 1,892 1,706 1,996 1,804 2,021 1,744 2,205 2,528 2,505 2,479 2,667 2,804
0 0 0 0 0 0 0 2 26 86 74 47
484 645 740 597 769 756 1,310 1,262 1,663 1,742 1,893 1,701
Total Liabilities 2,415 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,679 4,597
219 228 322 290 342 334 440 468 425 468 462 527
CWIP 127 217 1 17 24 36 47 56 76 98 109 6
Investments 4 4 29 68 50 0 0 41 52 38 41 54
2,066 1,939 2,422 2,062 2,410 2,164 3,062 3,270 3,686 3,749 4,066 4,010
Total Assets 2,415 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,679 4,597

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
138 282 200 206 157 121 433 666 687 216 609 952
427 -290 485 16 -8 38 -113 -29 7 64 83 0
-21 -480 -42 -590 -73 -581 -158 -148 -556 -703 -613 -656
Net Cash Flow 544 -488 644 -367 76 -421 162 489 138 -424 79 296

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 44 47 57 53 72 89 81 73 65 77 69 69
Inventory Days 106 98 85 169 178 175 294 206 226 235 268 194
Days Payable 42 51 40 52 67 67 164 101 142 127 129 76
Cash Conversion Cycle 108 94 102 171 184 197 211 177 149 185 208 187
Working Capital Days 79 88 53 92 104 134 116 77 62 87 89 84
ROCE % 29% 24% 31% 25% 23% 22% 25% 30% 31% 31% 34%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
71.43% 71.43% 71.43% 71.43% 71.43% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44%
2.97% 3.05% 2.99% 2.90% 2.95% 3.10% 3.19% 3.18% 3.18% 3.30% 3.53% 3.62%
11.34% 12.23% 12.53% 12.90% 13.10% 12.76% 12.78% 12.74% 13.06% 13.23% 12.70% 12.80%
14.26% 13.28% 13.05% 12.77% 12.51% 12.71% 12.59% 12.64% 12.32% 12.05% 12.33% 12.15%
No. of Shareholders 65,09362,32162,17860,23057,76057,89657,04857,25348,40445,32946,90745,852

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls